KKR to Invest in Life Sciences Firm Catalio Capital Management
Summary
Members of the Catalio Board of Advisors will include, among others, , the retired Chairman & CEO of Johnson & Johnson, , the retired Chairman & CEO of , , the Vice Chairman & President of Global Client Services at BDT & MSD, and Tim J. ONeill, a longtime Partner and retired Co-Head of Goldman Sachs Asset Management.The life sciences sector represents a growing market opportunity and has been an important area of focus for our health care growth strategy, which will be further accelerated through our partnership with Catalio. We believe that we will now be even better positioned to empower the worlds most innovative clinical scientists to turn next-generation biomedical discoveries into valuable treatments and cures and create profitable, well-run companies that advance the boundaries of care.Following the completion of the transaction, Mr. Petrocheilos and will continue to own a controlling stake in Catalio, and the day-to-day management and operation of the Catalio business will remain the same.KKR has a long track record of supporting health care companies globally, having committed over to the sector since 2004. KKRs health care growth strategy is focused on investing in high-growth health care-related companies to which KKR can be a unique strategic partner in helping reach scale.served as legal advisor to served as legal advisor to Catalio.KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. For additional information about , please visit Global Atlantic Financial Groups website at www.globalatlantic.com., is a multi-strategy life sciences investment firm focusing on breakthrough biomedical technology companies developing the next generation of drugs, devices, diagnostics, and data-driven insights. Catalio has partnered with over 44 world-renowned scientists with extensive academic and scientific achievements who have each also started well-established companies based on their research.